Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Sean McCarthy to be a panelist at CED's Business Development Partnering Forum at the NC Biotech Center in Research Triangle Park, NC.
News | 12. 10. 2007
